Company news

Rein Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer

May 31, 2020

Aileron Therapeutics Announces Initiation of Expansion Cohort and First Patient Enrolled into Expansion Cohort of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent

May 26, 2020

Aileron Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 10, 2020

Aileron Therapeutics Announces Plans to Release Interim Results from its Phase 1b/2 Myelopreservation Study in Mid-2020

April 21, 2020

Aileron Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

March 29, 2020

← Newer news releases

Decks